Viral Immunologists are researchers dedicated to understanding the complex relationship between the immune system and viruses. Their work focuses on how the body’s immune system detects and responds to viral infections, specifically how antibodies, T cells, and other immune components work together to neutralize viruses. These experts also study how viruses like HIV, hepatitis, influenza, and coronaviruses can evade the immune system, leading to chronic infections or immune suppression. Through this research, viral immunologists uncover crucial insights into viral pathogenesis, which aids in developing vaccines and therapies that enhance the body’s immune response to combat viral infections.
Viral immunologists play a vital role in designing vaccines and therapeutic interventions to prevent and treat viral diseases. They contribute to creating vaccines that induce strong, long-lasting immunity, and help develop antiviral drugs that target specific viral components. Their expertise is also integral to the development of immune-based therapies, such as monoclonal antibodies, that can help boost the immune system’s ability to fight off infections. Viral immunologists are essential in advancing the fight against viral infections, offering innovative solutions to improve global health. Their continued research is pivotal in shaping future vaccine and treatment strategies, offering hope for controlling viral outbreaks worldwide.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia